Neuroendocrine Tumor — Trials

Neuroendocrine Tumor — Trials · CancerIndex

Clinical trials

Registered studies

805 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 151–200 of 336 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02651987	Efficacy and Safety Study in Pancreatic or Midgut Neuroendocrine Tumours Having Progressed Radiologically While Previously Treated With Lanreotide Autogel® 120 mg(CLARINET FORTE)	completed	Phase 2	99	IpsenINDUSTRY	10	Oct 3, 2022	clinicaltrials
NCT01229943	Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery	completed	Phase 2	150	National Cancer Institute (NCI)NIH